Dr. Sofia Merajver
Dr. Sofia Merajver, M.D., Ph.D.
Professor, Department of Internal Medicine/Epidemiology
University of Michigan Health System
Education
B.S.: Mathematics, University of Maryland (1973)
M.S: Physics, University of Maryland (1975)
Ph.D.: Physics, University of Maryland (1978)
M.D.: University of Michigan Medical School (1987)
Research Interests
Dr. Merajver is Professor of Internal Medicine and Epidemiology; she is the Director of the Breast and Ovarian Cancer Risk Evaluation Program and Scientific Director of the Breast Oncology Program at the UM Comprehensive Cancer Center. Dr. Merajver's research is focused on the study of aggressive cancers, especially breast and women's cancers, though she also studies more broadly the roles of BRCA1 and other genes involved in hereditary breast and ovarian cancer syndromes and their impact on cancer risk assessments, both of which are critical to ovarian cancer prevention and management. Dr. Merajver's extensive experience with high-risk patients brings a clinical and translational focus to her research in systems biology, mathematical oncology, cancer genetics, global cancer epidemiology, and drug development.
Links
Lab Website
B.S.: Mathematics, University of Maryland (1973)
M.S: Physics, University of Maryland (1975)
Ph.D.: Physics, University of Maryland (1978)
M.D.: University of Michigan Medical School (1987)
Research Interests
Dr. Merajver is Professor of Internal Medicine and Epidemiology; she is the Director of the Breast and Ovarian Cancer Risk Evaluation Program and Scientific Director of the Breast Oncology Program at the UM Comprehensive Cancer Center. Dr. Merajver's research is focused on the study of aggressive cancers, especially breast and women's cancers, though she also studies more broadly the roles of BRCA1 and other genes involved in hereditary breast and ovarian cancer syndromes and their impact on cancer risk assessments, both of which are critical to ovarian cancer prevention and management. Dr. Merajver's extensive experience with high-risk patients brings a clinical and translational focus to her research in systems biology, mathematical oncology, cancer genetics, global cancer epidemiology, and drug development.
Links
Lab Website